Bristol-Myers Squibb

What happened a year ago this week in biopharma? August 12-18, 2018
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Flag link:
What happened a year ago this week in biopharma? August 12-18, 2018
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Flag link:
Celgene wins approval for drug key to Bristol buyout
Celgene wins approval for drug key to Bristol buyout
Biopharma Dive
Celgene
FDA
Inrebic
myelofibrosis
M&A
Bristol-Myers Squibb
Flag link:
Which pharmas grew most in Q2? AstraZeneca, Merck and BMS, for 3
Which pharmas grew most in Q2? AstraZeneca, Merck and BMS, for 3
Fierce Pharma
earnings
AstraZeneca
Merck
Bristol-Myers Squibb
Flag link:
Celgene Continues Growing While Waiting for its Acquisition to Close
Celgene Continues Growing While Waiting for its Acquisition to Close
Motley Fool
Celgene
earnings
M&A
Bristol-Myers Squibb
Flag link:
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
Yahoo/Motley Fool
Merck
Keytruda
AbbVie
Humira
Pfizer
Bristol-Myers Squibb
Eliquis
JNJ
Imbruvica
Flag link:
Wiping its slate ahead of BMS buy, Celgene to pay $117M in Revlimid antitrust settlements
Wiping its slate ahead of BMS buy, Celgene to pay $117M in Revlimid antitrust settlements
Fierce Pharma
Celgene
Bristol-Myers Squibb
antitrust
Flag link:
Anti-PD-1 Drug Opdivo Significantly Improves Five Year Survival In Advanced Cancers
Anti-PD-1 Drug Opdivo Significantly Improves Five Year Survival In Advanced Cancers
Forbes
advanced cancer
Opdivo
Bristol-Myers Squibb
advanced melanoma
Flag link:
Celgene Offers Beat-And-Raise As Bristol Merger Looms Closer
Celgene Offers Beat-And-Raise As Bristol Merger Looms Closer
Investors Business Daily
Celgene
earnings
M&A
Bristol-Myers Squibb
Flag link:
Sales gap grows between rival Merck, Bristol cancer therapies
Sales gap grows between rival Merck, Bristol cancer therapies
Biopharma Dive
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
cancer
Flag link:
Bristol's Celgene buyout 'more important' given drug pricing pressure, CEO says
Bristol's Celgene buyout 'more important' given drug pricing pressure, CEO says
Fierce Pharma
Bristol-Myers Squibb
Celgene
M&A
drug pricing
Giovanni Caforio
Flag link:
Bristol-Myers’ Rosy Outlook Trumps Trial Setback as Stock Gains
Bristol-Myers’ Rosy Outlook Trumps Trial Setback as Stock Gains
Yahoo/Bloomberg
earnings
Bristol-Myers Squibb
Opdivo
Flag link:
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck
Xconomy
Bristol-Myers Squibb
Merck
Keytruda
Opdivo
non-squamous
non-squamous non-small cell lung cancer
Flag link:
Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect
Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect
Marketwatch
Celgene
Biogen
AbbVie
Bristol-Myers Squibb
earnings
Flag link:
8 More Big Pharma Events in 2019 You Don't Want to Miss
8 More Big Pharma Events in 2019 You Don't Want to Miss
Motley Fool
Novartis
Pfizer
AbbVie
Bristol-Myers Squibb
Merck
GSK
Flag link:
Bristol-Myers, Ono, Bayer Team Up for Colorectal Cancer Study
Bristol-Myers, Ono, Bayer Team Up for Colorectal Cancer Study
Yahoo/Zacks.com
Bristol-Myers Squibb
Bayer
Ono Pharmaceutical
Opdivo
Stivarga
metastatic colorectal cancer
Flag link:
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Bristol-Myers Squibb
Celgene
M&A
Otezla
Gilead Sciences
Amgen
Regeneron
Eli Lilly
JNJ
Flag link:
Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer
Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer
BioSpace
Bayer
Bristol-Myers Squibb
Ono Pharmaceutical
metastatic colorectal cancer
Flag link:
Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019
Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019
Motley Fool
Bristol-Myers Squibb
Celgene
M&A
Flag link:
Pressing the pause button on CAR-T cells with Bristol-Myers’ leukemia drug
Pressing the pause button on CAR-T cells with Bristol-Myers’ leukemia drug
Fierce Biotech
CAR-T
Bristol-Myers Squibb
cytokine release syndrome
Flag link:

Pages